pramipexole has been researched along with Acute Confusional Senile Dementia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, J; Bothwell, R; Burns, J; Welch, P | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Aiello, L; Camponi, V; Carratelli, D; Cortese, M; Dignazio, L; Felli, B; Masin, AM; Morocutti, C; Pacitti, MT; Scoyni, RM; Trani, I | 1 |
| Abramova, NA; Bennett, JP; Cassarino, DS; Khan, SM; Painter, TW | 1 |
1 review(s) available for pramipexole and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
3 other study(ies) available for pramipexole and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Biomarkers; Brain; Female; Glucose; Humans; Male; Neuropsychological Tests; Nootropic Agents; Peptide Fragments; Positron-Emission Tomography; Pramipexole; Severity of Illness Index; tau Proteins; Treatment Outcome | 2016 |
Drug adverse events and drop-out risk: a clinical case.
Topics: Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzothiazoles; Brain; Dopamine Agonists; Drug Therapy; Female; Health Status; Humans; Magnetic Resonance Imaging; Mental Disorders; Parkinson Disease; Patient Dropouts; Pramipexole; Promazine; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2007 |
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.
Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured | 2002 |